venlafaxine hydrochloride has been researched along with quinoxalines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Béïque, J; Blier, P; de Montigny, C; Debonnel, G | 1 |
| Abdrashitova, NY; Bryushinina, OS; Frelikh, GA; Lakeev, AP; Tsuran, DV; Udut, VV; Yanovskaya, EA; Zyuz'kov, GN; Zyuz'kova, YG | 1 |
2 other study(ies) available for venlafaxine hydrochloride and quinoxalines
| Article | Year |
|---|---|
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Topics: Adrenergic alpha-Agonists; Animals; Autoreceptors; Brimonidine Tartrate; Carrier Proteins; Cricetinae; Cyclohexanols; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Symporters; Time Factors; Tritium; Venlafaxine Hydrochloride | 2000 |
Role of JNK in the Regulation of Xenobiotic Metabolizing Function of Hepatocytes.
Topics: Animals; Biotransformation; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Liver; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Oximes; Quinoxalines; Signal Transduction; Venlafaxine Hydrochloride; Xenobiotics | 2021 |